1 Broquist HP, Mason PS, Wickwire, et al. Swainsonine production in the mold Rhizoctonia leguminicola [J] . Plant Toxicology,1984,5(14-18):301~307
2 Croom WJ, Hagler WM, Froetschel MA, et al. The involvement of slaframine and swainsonine in slobbers syndrome: a review [J].American society of Animal science,1995,73(5):1499~1508
3 Broquist HP, Mason PS, Hagler WM, et al. Indentification of swaisonine as a probable contributory mycotoxin in moldy forage mycotoxicoses[J].American society for Microbiology,1984,48(2):386~388
4 Dennis J W, White S L, Freer A M, et al. Carbonoyloxy analogs of the anti-metastatic drug swainsonine [J].Biochem Pharmacol,1993,46(8):1459~1466
5 Mohla S, White S, Grzegorzewski K, et al. Inhibition of growth of subcutaneous xenografts and metastasis of human breast carcinoma by swainsonine: modulation of tumor cell HLA class I antigens and host immune effector mechanisms[J].Anticancer Res,1990,10(6):1515~1522
6 Breton P, Asseffa, Grzegorzewski K, et al. swaomsonine modulation of protein kinase Cactivity in murine peritoneal macrophages[J].Cancer Commun,1990,2(10):333~338
7 Humphries M J, Matsumoto K, White S L, et al. An assessment of the effects of swainsonine on survival of mice injected withB16-F10 melanoma cells [J]. Clin Exp Metastasis,1990,8:89~102
8 Houri J J, Ogier-Denis E, Bauvy C, et al. swainsonine is a useful tool to monitor the N-linked glycoprotein as a function of the state of enterocytic differentiation of HT-29 cells [J].Eur J Biochem,1992,205(3):1169~1174
9 Olden K, Breton P, Grzegorzewski K, et al. The potential importance of swainsonine in therapy for cancers and immunology [J].PharmacolTher,1991,50(3):285~290
10陶厚权.抗癌药swainsonine的基础与临床研究进展[J].国外医药－合成药、生化药、制剂分册,1997,18(1):34~36
11陶厚权.抗癌药swainsonine 的实验与临床研究进展[J].中国肿瘤临床,1996,23(11):822~824
12刘炳亚,林言笺,尹浩然,等.苦马豆素抑制胃癌生长及转移的实验研究[J].中华肿瘤杂志，1998,20(3):168~170
13杨鸣琦,曹光荣,李绍君.苦马豆素制备及其抗肿瘤作用的初步研究[J],动物毒物学,1996,11(1):19
14张守信,曹光荣,李绍君,等.甘肃棘豆醇提物对小鼠移植性肿瘤S37、H22的抑制试验[J].畜牧兽医杂志,1992,(2):13~15
|
